Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studies
Zuleide Maria Ignácio, A.V. Calixto, Ritele Hernandez da Silva, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 86, pp. 36-50
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

A Comprehensive Investigation of Interactions between Antipsychotic Drug Quetiapine and Human Serum Albumin Using Multi-Spectroscopic, Biochemical, and Molecular Modeling Approaches
Seema Zargar, Tanveer A. Wani, Nawaf A. Alsaif, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2589-2589
Open Access | Times Cited: 52
Neuronal nitric oxide synthase and affective disorders
Qi‐Gang Zhou, Xian‐Hui Zhu, Ashley D. Nemes, et al.
IBRO Reports (2018) Vol. 5, pp. 116-132
Open Access | Times Cited: 82
Direct Effects of Antipsychotics on Potassium Channels
Wenwen Zhuang, Seo‐Yeong Mun, Won Sun Park
Biochemical and Biophysical Research Communications (2025) Vol. 749, pp. 151344-151344
Closed Access
Antidepressant-like and neuroprotective effect of hydroalcoholic extract of Aloysia citriodora in animals subjected to childhood stress
Amanda Gollo Bertollo, Silvio José Batista Soares, Severina Silva Amaral, et al.
Research Square (Research Square) (2025)
Closed Access
Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs
Nicholas C. Borgogna, Tyler Owen, Dan Petrovitch, et al.
Psychopharmacology (2025)
Open Access
Quetiapine effect on depressive-like behaviors, oxidative balance, and inflammation in serum of rats submitted to chronic stress
Roberta Eduarda Grolli, Amanda Gollo Bertollo, João Paulo Behenck, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 7, pp. 1423-1433
Open Access | Times Cited: 7
Dose-Dependent Biphasic Action of Quetiapine on AMPK Signalling via 5-HT7 Receptor: Exploring Pathophysiology of Clinical and Adverse Effects of Quetiapine
Motohiro Okada, Kouji Fukuyama, Eishi Motomura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9103-9103
Open Access | Times Cited: 12
The Effect of Neuropsychiatric Drugs on the Oxidation-Reduction Balance in Therapy
Karina Sommerfeld, Wiktoria Jiers, Szymon Rzepczyk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7304-7304
Open Access | Times Cited: 2
Recent Advances in representative small-molecule DRD2 inhibitors: Synthetic Routes and clinical applications
Yao Zhang, Jiangang Yu, Wen Wen
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116731-116731
Closed Access | Times Cited: 2
Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent
L Giuntoli, V. Dalmastri, Nicola Cilloni, et al.
The International Journal of Artificial Organs (2019) Vol. 42, Iss. 9, pp. 516-520
Closed Access | Times Cited: 17
Antidepressant efficacy and side effect burden: an updated guide for clinicians
Tatum Kutzer, Michèlle Dick, Trevor Scudamore, et al.
Drugs in Context (2020) Vol. 9, pp. 1-11
Open Access | Times Cited: 13
Testosterone Replacement Therapy in the Treatment of Depression
Danyon J. Anderson, Parsia Vazirnia, Catherine Loehr, et al.
Health psychology research (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 7
Synergistic effect of aripiprazole and escitalopram in increasing serotonin but not norepinephrine neurotransmission in the rat hippocampus
Mohammad Ali Ebrahimzadeh, Mostafa El Mansari, Pierre Blier
Neuropharmacology (2018) Vol. 146, pp. 12-18
Closed Access | Times Cited: 11
Treatment-resistant depression: Neurobiological correlates and the effect of sleep deprivation with sleep phase advance for the augmentation of pharmacotherapy
Ewa Kurczewska, Ewa Ferensztajn‐Rochowiak, Filip Rybakowski, et al.
The World Journal of Biological Psychiatry (2020) Vol. 22, Iss. 1, pp. 58-69
Closed Access | Times Cited: 9
Treatment with the second-generation antipsychotic quetiapine is associated with increased subgenual ACC activation during reward processing in major depressive disorder
Nicola Omlor, Maike Richter, Janik Goltermann, et al.
Journal of Affective Disorders (2023) Vol. 329, pp. 404-412
Closed Access | Times Cited: 2
Comparative efficacy and safety of 4 atypical antipsychotics augmentation treatment for major depressive disorder in adults: A systematic review and network meta-analysis
Jia Wang, Wenwei Li, Mengting Li, et al.
Medicine (2023) Vol. 102, Iss. 38, pp. e34670-e34670
Open Access | Times Cited: 2
Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles
Xiaomei Huang, Suhua Zhang, Yan-xia Ma, et al.
Drug Design Development and Therapy (2018) Vol. Volume 13, pp. 255-264
Open Access | Times Cited: 5
Chronic administration of quetiapine stimulates dorsal hippocampal proliferation and immature neurons of male rats, but does not reverse psychosocial stress-induced hyponeophagic behavior
Yusuke Murata, Hiroko Matsuda, Yoko Mikami, et al.
Psychiatry Research (2018) Vol. 272, pp. 411-418
Closed Access | Times Cited: 4
Low-dose Quetiapine for Major Depressive Disorder and Sleep Improvement
Evyn M. Peters, Rudy Bowen, Lloyd Balbuena
Journal of Clinical Psychopharmacology (2020) Vol. 40, Iss. 5, pp. 500-502
Closed Access | Times Cited: 4
Comparing outcomes in chronic depression following inpatient psychotherapy for patients continuing versus discontinuing antidepressant medication
Andreas Høstmælingen, Pål Ulvenes, Helene Amundsen Nissen‐Lie, et al.
Clinical Psychology & Psychotherapy (2021) Vol. 28, Iss. 5, pp. 1111-1127
Open Access | Times Cited: 4
Trajectories of change in chronic depression: Differences in self-criticism and somatic symptoms between users of antidepressants and nonmedicated patients.
Andreas Høstmælingen, Pål Ulvenes, Helene Amundsen Nissen‐Lie, et al.
Journal of Counseling Psychology (2021) Vol. 69, Iss. 1, pp. 85-99
Open Access | Times Cited: 4
Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission
Morozova Ma, С. С. Потанин, D. S. Burminskiy, et al.
S S Korsakov Journal of Neurology and Psychiatry (2022) Vol. 122, Iss. 8, pp. 120-120
Closed Access | Times Cited: 3
Impact of quetiapine on ion channels and contractile dynamics in rat ventricular myocyte
Orhan Erkan, Nihal Öztürk, Semir Özdemir
European Journal of Pharmacology (2024) Vol. 976, pp. 176674-176674
Closed Access
MIP-Based Electrochemical Sensors in the Detection of Opioids, Benzodiazepines and Psychoactive Compounds
Khadijeh Nekoueian, Tomi Laurila
(2024), pp. 101-131
Closed Access
Pharmaceutical applications of 1,5-benzothiazepines
Elaheh Akbarzadeh
Elsevier eBooks (2022), pp. 295-320
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top